preCARDIA
- Company typePrivate
- Founded2017
- HeadquartersSaint Paul, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
preCARDIA firmographics
Firmographics- Name
- preCARDIA
- Website
- https://precardia.com
- Company type
- Private
- Founded year
- 2017
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
preCARDIA industry classification
Industry- Product category
- Cardiac Medical Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Cardiac Assist & Heart Failure Therapies (Implantables, Neuromodulation) (HLAHAFAL)
- akta.pro secondary industry
- Mechanical Circulatory Support (VAD, IABP, ECMO) (HLAHAFAG)
Keywords
Where preCARDIA is headquartered
LocationHeadquarters
- HQ city
- Saint Paul
- HQ country
- United States
- HQ region
- North America
Markets served
preCARDIA business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales
preCARDIA product offering
Product offeringCore offering
preCARDIA develops and provides inpatient partially implantable medical devices designed to treat patients suffering from acute decompensated heart failure (ADHF). The device is used in hospital settings as a therapeutic intervention to manage fluid overload and cardiac decompensation in acutely ill heart failure patients.
Differentiator
Problem solved
Functional benefit
Products and services
- preCARDIA Inpatient Partially Implantable Heart Failure Device A partially implantable medical device intended for inpatient use in treating patients with acute decompensated heart failure. Designed for hospital-based therapeutic intervention to manage acute cardiac decompensation.
Companies that use preCARDIA
Customer profileIdeal customer profiles1 record
preCARDIA technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
preCARDIA competitors and assessment
Company assessmentEmerging players
- BioVentrix: Developer of the Revivent TC system for ventricular reshaping in heart failure patients — a structural heart device peer focused on remodeling therapies for failing ventricles.
- Procyrion: Develops the Aortix percutaneous circulatory support device for acute decompensated heart failure — a small, venture-backed peer pursuing a similar inpatient, catheter-delivered heart failure therapy.
- Cardiac Dimensions: Developer of the Carillon system, a catheter-based mitral annuloplasty device for functional mitral regurgitation in heart failure — a structurally similar catheter-delivered implant approach.
- Corvia Medical: Developer of the Corvia Atrial Shunt, an implantable interatrial shunt device for heart failure with preserved ejection fraction — comparable as a small, venture-backed developer of catheter-delivered heart failure implants.
- Ancora Heart: Developer of the AccuCinch system, a transcatheter ventricular restoration device for heart failure, with similar partially catheter-delivered implant positioning in the heart failure treatment paradigm.
- Magenta Medical: Israel-based developer of an endovascular heart pump for high-risk PCI and cardiogenic shock, a close clinical and technological peer for catheter-based heart failure devices.
Broad incumbents
- Abbott: Sells the HeartMate durable VAD and a broad cardiovascular portfolio, making it a key incumbent in the heart failure device space and a relevant strategic benchmark for preCARDIA.
- Edwards Lifesciences: A major cardiovascular medtech with heart failure and structural heart franchises; competes in adjacent device-based heart failure management and is a likely strategic acquirer of focused ADHF assets.
- Abiomed: Acquired by Johnson & Johnson, Abiomed is a leader in temporary mechanical circulatory support (Impella) used in the inpatient heart failure and high-risk PCI setting — directly relevant to preCARDIA's inpatient ADHF device focus.
- Medtronic: Global cardiovascular device leader with heart failure, cardiac surgery, and rhythm management franchises; relevant as both a competitive and potential strategic counterparty for heart failure device developers.
Market position
Customer concentration
preCARDIA social profiles
Digital presencepreCARDIA financial estimates
Financial estimateRevenue estimate
Valuation estimate
preCARDIA leadership team
Management profileNumber of profiles
preCARDIA funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
preCARDIA M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about preCARDIA
What does preCARDIA do?
preCARDIA develops and provides inpatient partially implantable medical devices designed to treat patients suffering from acute decompensated heart failure (ADHF). The device is used in hospital settings as a therapeutic intervention to manage fluid overload and cardiac decompensation in acutely ill heart failure patients.
When was preCARDIA founded?
preCARDIA was founded in 2017. It employs 1 to 10 people.
Where is preCARDIA based?
preCARDIA is headquartered in Saint Paul, United States, in the North America region.
Who are preCARDIA's main competitors?
Emerging players on record are BioVentrix, Procyrion, Cardiac Dimensions, Corvia Medical, Ancora Heart and Magenta Medical. Broad incumbents are Abbott, Edwards Lifesciences, Abiomed and Medtronic.
Does preCARDIA have an API?
No public API is recorded for preCARDIA.
What industry is preCARDIA in?
preCARDIA's product category is Cardiac Medical Devices. Its primary akta.pro industry code is HLAHAFAL, Cardiac Assist & Heart Failure Therapies (Implantables, Neuromodulation), with a secondary code of HLAHAFAG, Mechanical Circulatory Support (VAD, IABP, ECMO). Its NAICS code is 334510 and its SIC code is 3841.